Lonza is coming to you.
Join us for the very first Lonza Cell Therapy Roadshow, a unique opportunity to connect in person with our Cell Therapy Process Development experts. Whether you’re advancing autologous, allogeneic, or iPSC-based therapies, this is a chance to discuss your process development goals, explore scientific approaches, and gain insight into how Lonza helps innovators transition from bench to IND.
What to Expect:
In 1:1 or small group discussions, we’ll cover the latest technical capabilities and strategic investments designed to accelerate your cell therapy journey:
What We’ll Cover
🔹 Autologous Cell Therapy
From first-in-human studies to early clinical to commercial manufacturing, we offer experience-backed support in process development, quality strategy, and early automation to help reduce COGS and prepare your therapy for clinical readiness.
🔹 Allogeneic Cell Therapy
Our teams specialize in optimizing early-stage allogeneic platforms with line of site to commercial readiness, including strategies to close 2D processes and transition to 3D systems, improving scalability and consistency from the outset.
🔹 iPSC-Based Therapies
With a dedicated iPSC process development lab and a collaborative mindset, we help clients tackle bioprocessing challenges such as differentiation, expansion, and scale-up, enabling robust clinical supply.
Let’s Talk Science – In Person
We’re scheduling private sessions on May 28–29, 2025, in the Boston area. These tailored discussions are designed for R&D, technical and manufacturing teams preparing for or entering clinical development.
Meet the experts:
- Ravi Vyzasatya, Head of Technical Sales, former Head of Cell Therapy Process Development
- Rahul Purohit, Associate Director, Cell Therapy Technical Sales
- Thomas Richardson, Development Manager, Cell Therapy Process Development
➡️ Reserve your meeting now and reach out to your dedicated Sales Representative Erin Gilbert at erin.gilbert@lonza.com